EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of Clodronate on the Pathogenesis in a Mouse Model of Lysosomal Acid Lipase Deficiency

Ryuichi Mashima, Shuji Takada iD, Kei Murayama, Takashi Hamazaki

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27198694 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Ryuichi Mashima und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Medicine, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan. Hauptthemen laut MEDLINE: Clodronic Acid, Wolman Disease. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Sanofi LSD grant, Sanofi LSD.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lysosomal acid lipase deficiency (LAL-D, OMIM #309900), caused by mutations of the LIPA gene, is involved in two continuum disease phenotypes: Wolman disease in infants and cholesteryl ester storage disease in adults. Their major phenotypes include steatosis, hepatomegaly, splenomegaly, and elevated liver enzymes. Enzyme replacement therapy has been used for the treatment of LAL-D. In this study, we examined the therapeutic effect of liposomal clodronate in an LAL-D mouse model. When liposomal clodronate was administered intraperitoneally by a single administration at 200 mg/kg to adult mice, organ cholesterol and triglyceride levels partially decreased. Furthermore, a significant correction of the relative organ weight of the liver and spleen as well as a reduction in splenic lipids were observed when liposomal clodronate was administered at 50 mg/kg to young mice intraperitoneally by multiple administrations. These results demonstrate that liposomal clodronate might have a therapeutic effect on the LAL-D mouse model.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clodronic AcidWolman DiseaseAnimalsMiceDisease Models, AnimalLiverSterol EsteraseTriglyceridesSpleenCholesterolLiposomesMaleOrgan Size

Stichwörter der Autor:innen

Lysosomal acid lipase deficiencyclodronatemacrophage

Substanzen

Clodronic AcidSterol EsteraseTriglyceridesCholesterolLiposomes

Autor:innen und Institutionen

  • Department of Clinical Laboratory Medicine, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan.
  • Department of Systems BioMedicine, National Research Institute for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan.
  • Diagnostics and Therapeutics of Intractable Diseases, Intractable Disease Research Center, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo 113-8421, Japan.
  • Department of Pediatrics, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8585, Japan.

ORCID-Profile: Shuji Takada

Förderung

  • Japan Society for the Promotion of Science
  • Sanofi LSD grant
  • Sanofi LSD

Zitieren

APA

Mashima, R., Takada, S., Murayama, K., & Hamazaki, T. (2026). Effect of Clodronate on the Pathogenesis in a Mouse Model of Lysosomal Acid Lipase Deficiency. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27198694

Vancouver

Mashima R, Takada S, Murayama K, Hamazaki T. Effect of Clodronate on the Pathogenesis in a Mouse Model of Lysosomal Acid Lipase Deficiency. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27198694

BibTeX
@article{Mashima2026,
  author = {Mashima, Ryuichi and Takada, Shuji and Murayama, Kei and Hamazaki, Takashi},
  title = {Effect of Clodronate on the Pathogenesis in a Mouse Model of Lysosomal Acid Lipase Deficiency},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27198694}
}
Kostenlos starten →